Compare · GDRX vs INFY
GDRX vs INFY
Side-by-side comparison of GoodRx Holdings Inc. (GDRX) and Infosys Limited (INFY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GDRX and INFY operate in EDP Services (Technology), so they compete in similar markets.
- INFY is the larger of the two at $48.80B, about 41.2x GDRX ($1.19B).
- Over the past year, GDRX is down 19.9% and INFY is down 30.1% - GDRX leads by 10.2 points.
- GDRX has been more active in the news (10 items in the past 4 weeks vs 3 for INFY).
- Both have 25 recent analyst ratings on file.
- Company
- GoodRx Holdings Inc.
- Infosys Limited
- Price
- $3.48+1.02%
- $12.04+1.86%
- Market cap
- $1.19B
- $48.80B
- 1M return
- +14.31%
- +2.64%
- 1Y return
- -19.93%
- -30.10%
- Industry
- EDP Services
- EDP Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- News (4w)
- 10
- 3
- Recent ratings
- 25
- 25
GoodRx Holdings Inc.
GoodRx Holdings, Inc., through its subsidiaries, provides information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including telehealth services. The company serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.
Infosys Limited
Infosys Limited, together with its subsidiaries, provides consulting, technology, outsourcing, and next-generation digital services in North America, Europe, India, and internationally. It provides application development and management, independent validation, product engineering and management, infrastructure management, enterprise application management, and support and integration services. The company's products and platforms include Finacle, a core banking solution; Edge suite of products; Infosys Nia, an artificial intelligence platform; Infosys McCamish - an insurance platform; Wingspan, a customizable learning platform; Stater mortgage servicing platform; Panaya automation suite; and Skava, an e-commerce suite. The company serves clients in the financial services and insurance, life sciences and healthcare, manufacturing, retail, consumer packaged goods and logistics, hi-tech, communications, telecom OEM, media, energy, utilities, resources, services, and other industries. It has collaboration agreements with Rolls-Royce, BP plc, Newmont Corporation, RXR Realty, Majesco Limited, and Centre for Accessibility Australia. The company was formerly known as Infosys Technologies Limited and changed its name to Infosys Limited in June 2011. Infosys Limited was incorporated in 1981 and is headquartered in Bengaluru, India.
Latest GDRX
- Large owner Francisco Partners Iv, L.P. converted options into 7,500,000 shares, disposed of 4,739,005 shares and sold $4,201,230 worth of shares (1,193,951 units at $3.52) (SEC Form 4)
- SEC Form 144 filed by GoodRx Holdings Inc.
- Chief Accounting Officer Chan Thomas (Tc) converted options into 10,115 shares and covered exercise/tax liability with 5,149 shares, increasing direct ownership by 58% to 13,546 units (SEC Form 4)
- Officer Fengler Justin converted options into 48,532 shares and covered exercise/tax liability with 21,407 shares, increasing direct ownership by 115% to 50,776 units (SEC Form 4)
- SEC Form 4 filed by Officer Fengler Justin
- New insider Fengler Justin claimed ownership of 23,651 shares (SEC Form 3)
- GoodRx Holdings Inc. filed SEC Form 8-K: Leadership Update
- SEC Form 10-Q filed by GoodRx Holdings Inc.
- GoodRx Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GoodRx Reports Second Quarter 2026 Results
Latest INFY
- Infosys downgraded by CLSA
- Infosys Collaborates with Knorr-Bremse to Accelerate AI-Enabled Enterprise Transformation
- Infosys and Metsä Group Expand Strategic Collaboration to Drive AI-led IT Transformation
- Investec Selects Infosys Finacle SaaS Platform on Microsoft Azure for Digital Banking Transformation
- SEC Form 6-K filed by Infosys Limited
- SEC Form 6-K filed by Infosys Limited
- Infosys downgraded by Analyst with a new price target
- Infosys downgraded by HSBC Securities
- SEC Form 6-K filed by Infosys Limited
- Infosys: AI Revenues at 8.2% in Q1; Resilient Operating Margin of 21.1%